CDEK
← Mechanisms of action

CD38

SINGLE PROTEINHomo sapiens
Preferred name: Lymphocyte differentiation antigen CD38 ChEMBL ↗

Linked proteins

Drugs acting on this target (49)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
cid-103AdccexperimentalmAbCD38
gen3014AdccexperimentalmAbCD38
sg2501AntagonistexperimentalmAbCD38
tnb-738AntagonistexperimentalmAbCD38
daratumumab (darzalex)Binding agentapprovedmAbCD38 binding agent
igm-2644Binding agentexperimentalmAbCD38 binding agent
isb 2001Binding agentexperimentalmAbCD38 binding agent
mt-0169Binding agentexperimentalRecombinant proteinCD38 binding agent
okt10-b10Binding agentexperimentalmAbCD38
sar442257Binding agentexperimentalmAbCD38
tak-079Binding agentexperimentalmAbLymphocyte differentiation antigen CD38 binding agent
XMab-15426Binding agentexperimentalmAbCD38
xmab18968Binding agentexperimentalmAbCD38
y150Binding agentexperimentalmAbCD38
cart-38 celllsImmunity, passiveexperimentalCell therapyCD38 immunity, passive
cll1 and cd38 dual-target car-t injectionImmunity, passiveexperimentalCell therapyCD38 immunity, passive
sti-1492Immunity, passiveexperimentalCell therapyCD38 immunity, passive
abbv-438InhibitorexperimentalmAbCD38 inhibitor
anti-cd38InhibitorexperimentalmAbCD38 inhibitor
cm313InhibitorexperimentalSmall moleculeCD38 inhibitor
daratumumab (darzalex)InhibitorapprovedmAbCD38 inhibitor
hlx15InhibitorexperimentalmAbCD38 inhibitor
Isatuximab (Sarclisa)InhibitorapprovedmAbCD38 inhibitor
isb 1442InhibitorexperimentalmAbCD38 inhibitor
kp1237InhibitorexperimentalmAbCD38 inhibitor
lx102InhibitorexperimentalSmall moleculeCD38 inhibitor
mor202InhibitorexperimentalmAbLymphocyte differentiation antigen CD38 inhibitor
prv-015InhibitorexperimentalmAbCD38 inhibitor
regn7945InhibitorexperimentalmAbCD38 inhibitor
sctc21cInhibitorexperimentalmAbCD38 inhibitor
sg301InhibitorexperimentalmAbCD38 inhibitor
vp301InhibitorexperimentalmAbCD38 inhibitor
zg006InhibitorexperimentalSmall moleculeCD38 inhibitor
89zr-amg211RadiopharmaceuticalexperimentalmAbCD38 radiopharmaceutical
64cu-dota-daratumumabSupplementationexperimentalmAbCD38 supplementation
89zr-dfo-daratumumabSupplementationexperimentalmAbCD38 supplementation
amg 424SupplementationexperimentalmAbCD38 supplementation
daratumumab (darzalex)SupplementationapprovedmAbCD38 supplementation
gbr 1342SupplementationexperimentalmAbCD38 supplementation
Isatuximab (Sarclisa)SupplementationapprovedmAbCD38 supplementation
jnj-70218902SupplementationexperimentalmAbCD38 supplementation
mor03087SupplementationexperimentalmAbCD38 supplementation
mor202SupplementationexperimentalmAbCD38 supplementation
sar442085SupplementationexperimentalmAbCD38 supplementation
sti-6129SupplementationexperimentalmAbCD38 supplementation
tak-079SupplementationexperimentalmAbCD38 supplementation
tak-169SupplementationexperimentalmAbCD38 supplementation
tak-573SupplementationexperimentalmAbCD38 supplementation
tj202SupplementationexperimentalmAbCD38 supplementation